Business Description
RayzeBio inc
NAICS : 541714
SIC : 2833
ISIN : US75525N1072
Description
RayzeBio inc is a company operating as vertically integrated radiopharmaceutical therapeutics company. The main objective of the company is defeating cancer with radiopharmaceutical medicines. It has a created a pipeline of multiple drug candidates, in therapeutic areas with significant market opportunities. They have a portfolio of potential RPT drug and development candidates that includes late-stage clinical programs, development programs and discovery programs.
Financial Strength
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 55.55 | |||||
| Equity-to-Asset | 0.95 | |||||
| Debt-to-Equity | 0.02 | |||||
| Debt-to-EBITDA | -0.26 | |||||
| Interest Coverage | N/A |
N/A
|
N/A
| |||
| Piotroski F-Score | 3/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History |
|---|
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 88.26 | |||||
| 9-Day RSI | 88.78 | |||||
| 14-Day RSI | 88.17 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 31.85 | |||||
| Quick Ratio | 31.85 | |||||
| Cash Ratio | 31.56 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Shareholder Yield % | -0.03 |
Profitability Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROE % | -30.04 | |||||
| ROA % | -8 | |||||
| ROIC % | -83.84 | |||||
| ROC (Joel Greenblatt) % | -92.64 | |||||
| ROCE % | -9.84 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PB Ratio | 6.5 | |||||
| Price-to-Tangible-Book | 6.5 | |||||
| EV-to-EBIT | -82.33 | |||||
| EV-to-EBITDA | -84.31 | |||||
| EV-to-FCF | -52.98 | |||||
| Price-to-Net-Current-Asset-Value | 7.23 | |||||
| Price-to-Net-Cash | 7.3 | |||||
| Earnings Yield (Greenblatt) % | -1.21 | |||||
| FCF Yield % | -1.62 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:RYZB
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
RayzeBio inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | |||
| EPS (TTM) ($) | -1.625 | ||
| Beta | 0 | ||
| Volatility % | 0 | ||
| 14-Day RSI | 88.17 | ||
| 14-Day ATR ($) | 0.168253 | ||
| 20-Day SMA ($) | 62.4325 | ||
| 12-1 Month Momentum % | 0 | ||
| 52-Week Range ($) | 17.95 - 62.51 | ||
| Shares Outstanding (Mil) | 60.02 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
RayzeBio inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
RayzeBio inc Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
RayzeBio inc Frequently Asked Questions
What is RayzeBio inc(RYZB)'s stock price today?
The current price of RYZB is $62.49. The 52 week high of RYZB is $62.51 and 52 week low is $17.95.
When is next earnings date of RayzeBio inc(RYZB)?
The next earnings date of RayzeBio inc(RYZB) is 2024-05-31 Est..
Does RayzeBio inc(RYZB) pay dividends? If so, how much?
RayzeBio inc(RYZB) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers